1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Chemotherapy Induced Nausea and Vomiting- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

DelveInsight’s, “ Chemotherapy Induced Nausea and Vomiting- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- A snapshot of the global Market therapeutics scenario for Chemotherapy Induced Nausea and Vomiting.
- A review of the marketed products under prescription for Chemotherapy Induced Nausea and Vomiting, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Chemotherapy Induced Nausea and Vomiting with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Chemotherapy Induced Nausea and Vomiting drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Chemotherapy Induced Nausea and Vomiting drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Chemotherapy Induced Nausea and Vomiting drugs.
- Coverage of Chemotherapy Induced Nausea and Vomiting Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2011-2015.

Reasons to buy
- Evaluate the marketing status and exclusivity details of Chemotherapy Induced Nausea and Vomiting key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Chemotherapy Induced Nausea and Vomiting.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
- API intelligence over marketed drugs for Chemotherapy Induced Nausea and Vomiting and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Chemotherapy Induced Nausea and Vomiting.
- Uncovering opportunities in the rapidly growing the US markets.

Table Of Contents

Chemotherapy Induced Nausea and Vomiting- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
- Indication Overview
- Marketed Drugs Assessment
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- The API Manufacturers by the United States Drug Master File (US DMF) Status
- The API Manufacturers by the US DMF Status (Drug Specific)
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
- The API Manufacturers by the US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figures (2011-2015)
- Marketed Drugs Information
- Drugs Description
- Route of Synthesis
- Global Active Pharmaceutical Manufacturers
- Approval Status
- Patent and Exclusivity Details
- Company Overview
- Phase III Drugs Information
- Phase III Drugs Description
- The United States Drug Master Filings (US DMF)
- Discontinued Drugs Information

List of Tables
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, (Year), 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, API Manufacturers by US DMF Status, 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Chemotherapy Induced Nausea and Vomiting Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, Global Sales (in million USD), 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, API Manufacturers, Global, 2014
Chemotherapy Induced Nausea and Vomiting Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Chemotherapy Induced Nausea and Vomiting, 2014

List of Figures
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, US, (Year), 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Chemotherapy Induced Nausea and Vomiting Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Chemotherapy Induced Nausea and Vomiting Therapeutic Market, Global Sales (in million USD), 2014
Chemotherapy Induced Nausea and Vomiting Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Doxorubicin Market By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2013 - 2024

Doxorubicin Market By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global doxorubicin market was valued at USD 0.81 billion in 2015 and is expected to reach a value of USD 1.38 billion by 2024, according to a new report by Grand View Research, Inc. The growing numbe ...

Global Colorectal Cancer Diagnostics & Therapeutics Market

Global Colorectal Cancer Diagnostics & Therapeutics Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global colorectal cancer diagnostics and therapeutics market is expected to grow at a CAGR of around 6% during the forecast period 2016-2021. The market is estimated to be valued at USD 8000 million ...

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About CINV Drugs The launch of extended half-life drugs in the market is expected to substantially improve the adoption rates, owing to their ability to act for prolonged periods of time. For instance, ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the Netherlands

  • January 2017
    5 pages
  • Therapy  

  • Netherlands  

View report >

Dermatological Treatment Market in the US

  • January 2017
    12 pages
  • Dermatological ...  

    Chemotherapy  

  • United States  

View report >

Therapy Market and Chemotherapy Market in Europe - Forecast

  • January 2017
    28 pages
  • Therapy  

    Chemotherapy  

    Breast Cancer  

  • Europe  

View report >

Therapy Market

3 days ago

Related Market Segments :

Chemotherapy

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.